Signatope
Desconocido
RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting...
SIGNATOPE GMBH
participó en un
H2020:
H2020-SC1-BHC-2018-2020
The vision of the RISK-HUNT3R consortium is to develop a reliable, efficient and cost-effective chemical safety assessment approach. It will...
2021-01-22 - 2026-05-31 | Financiado
2021-01-22 - 2026-05-31 | Financiado
TransBioLine: Translational Safety Biomarker Pipeline TransBioLine Enabling development and implementation of n...
SIGNATOPE GMBH
participó en un
H2020:
H2020-JTI-IMI2-2017-13-two-stage
Qualified biomarkers help to optimize drug development and patient safety, yet for the regulatory acceptance of safety biomarkers substantia...
2019-04-08 - 2025-01-31 | Financiado
2019-04-08 - 2025-01-31 | Financiado
* No se disponen de datos de la empresa actual.